These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3552712)
61. Quantification of Histidine-Rich Protein 3 of Plasmodium falciparum. Palani B Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):87-90. PubMed ID: 29634395 [TBL] [Abstract][Full Text] [Related]
62. Selection of an adjuvant for vaccination with the malaria antigen, MSA-2. Pye D; Vandenberg KL; Dyer SL; Irving DO; Goss NH; Woodrow GC; Saul A; Alving CR; Richards RL; Ballou WR; Wu MJ; Skoff K; Anders RF Vaccine; 1997 Jun; 15(9):1017-23. PubMed ID: 9261951 [TBL] [Abstract][Full Text] [Related]
63. Field evaluation of an enzyme-linked immunosorbent assay (ELISA) for Plasmodium falciparum sporozoite detection in anopheline mosquitoes from Kenya. Beier JC; Perkins PV; Wirtz RA; Whitmire RE; Mugambi M; Hockmeyer WT Am J Trop Med Hyg; 1987 May; 36(3):459-68. PubMed ID: 3555134 [TBL] [Abstract][Full Text] [Related]
64. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia. Lew AM; Anders RF; Edwards SJ; Langford CJ Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855 [TBL] [Abstract][Full Text] [Related]
65. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers. Nardin EH; Nussenzweig RS; Altszuler R; Herrington D; Levine M; Murphy J; Davis J; Bathurst I; Barr P; Romero P Bull World Health Organ; 1990; 68 Suppl(Suppl):85-7. PubMed ID: 2094595 [TBL] [Abstract][Full Text] [Related]
66. Structural basis for antibody recognition of the NANP repeats in Oyen D; Torres JL; Wille-Reece U; Ockenhouse CF; Emerling D; Glanville J; Volkmuth W; Flores-Garcia Y; Zavala F; Ward AB; King CR; Wilson IA Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10438-E10445. PubMed ID: 29138320 [TBL] [Abstract][Full Text] [Related]
67. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein. Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633 [TBL] [Abstract][Full Text] [Related]
68. Development, characterization and immunogenicity of a multi-stage, multi-valent Plasmodium falciparum vaccine antigen (FALVAC-1A) expressed in Escherichia coli. Zhou Z; Todd CW; Wohlhueter RM; Price A; Xiao L; Schnake P; Bonner PC; Martin AM; Goldman IF; De La Vega P; Udhayakumar V; Lal AA Hum Vaccin; 2006; 2(1):14-23. PubMed ID: 17012909 [TBL] [Abstract][Full Text] [Related]
69. Development of a sporozoite malaria vaccine. Nussenzweig V; Nussenzweig RS Am J Trop Med Hyg; 1986 Jul; 35(4):678-88. PubMed ID: 2425647 [No Abstract] [Full Text] [Related]
70. Plasmodium falciparum: induction of biologically active antibodies to gp195 is dependent on the choice of adjuvants. Hui GS; Chang SP Exp Parasitol; 1992 Aug; 75(1):155-7. PubMed ID: 1639161 [No Abstract] [Full Text] [Related]
71. T-cell antigenic sites of the malaria circumsporozoite protein. Good MF; Kumar S; Weiss WR; Miller LH Blood; 1989 Aug; 74(3):895-900. PubMed ID: 2665866 [No Abstract] [Full Text] [Related]
72. Differences in malaria vector biting behavior and changing vulnerability to malaria transmission in contrasting ecosystems of western Kenya. Nzioki I; Machani MG; Onyango SA; Kabui KK; Githeko AK; Ochomo E; Yan G; Afrane YA Parasit Vectors; 2023 Oct; 16(1):376. PubMed ID: 37864217 [TBL] [Abstract][Full Text] [Related]
73. Malaria among children under 10 years in 4 endemic health areas in Kisantu Health Zone: epidemiology and transmission. Ilombe G; Matangila JR; Lulebo A; Mutombo P; Linsuke S; Maketa V; Mabanzila B; Wat'senga F; Van Bortel W; Fiacre A; Irish SR; Lutumba P; Van Geertruyden JP Malar J; 2023 Jan; 22(1):3. PubMed ID: 36604663 [TBL] [Abstract][Full Text] [Related]
80. The impact of long-lasting microbial larvicides in reducing malaria transmission and clinical malaria incidence: study protocol for a cluster randomized controlled trial. Zhou G; Wiseman V; Atieli HE; Lee MC; Githeko AK; Yan G Trials; 2016 Aug; 17(1):423. PubMed ID: 27558161 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]